Dupixent 200 MG/1.14 ML pen 1.14ML
Ended Awarded Last action
- Contract number
- SPE2DR26F4D8L
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $44,212
Award facts
- Contract value 100% obligated
- $44,211.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $44,211.64 delivery order to AmerisourceBergen Drug Corp on December 19, 2025, for the supply of Dupixent 200 mg/1.14 mL pen injectors. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of December 22, 2025, to be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic medication used to treat various inflammatory conditions including atopic dermatitis, asthma, and eosinophilic esophagitis, representing a specialized pharmaceutical product within the military and federal healthcare supply chain.
This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical supply agreement valued at $999,999,999.00 and running through December 2026. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen maintains an extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies to support military healthcare systems worldwide. The non-competitive nature of this delivery order reflects the established relationship under the prime IDC, which enables DLA to efficiently procure critical pharmaceutical commodities for Defense Health Agency, U.S. Coast Guard, and other federal healthcare entities.
Quick answers
Who was awarded contract SPE2DR26F4D8L?
SPE2DR26F4D8L was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 19, 2025.
How much is contract SPE2DR26F4D8L worth?
The government has obligated $44,212 on SPE2DR26F4D8L.
Is contract SPE2DR26F4D8L an order under another contract?
Yes. SPE2DR26F4D8L is a delivery order under SPE2DR25D3012, an indefinite delivery contract.
Was contract SPE2DR26F4D8L competed?
The extent of competition for SPE2DR26F4D8L was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award